GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NeOnc Technologies Holdings NTHI · USD

Health Care · US listing · 🇺🇸 United States

Compare

3.74

+7.16%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$83,000

FY2021FY2024

Net income

−$11.9m

FY2021FY2024

Free cash flow

−$4.2m

FY2021FY2024

Shareholders' equity

−$5.5m

FY2021FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021
Revenue$83,000$70,462$20,000—
Gross profit$83,000$70,462$20,000—
Research and development$3.0m$1.5m$1.2m$674,558
Operating income−$7.1m−$12.2m−$2.8m−$3.3m
Net income−$11.9m−$14.9m−$3.0m−$3.4m
Diluted earnings per share-0.63-0.80-0.16-0.18

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021
Total assets$3.4m$1.3m$728,682$32,491
Cash and short-term investments$64,893$31,862$633,298$25,034
Total liabilities$8.9m$15.3m$2.3m$2.6m
Debt—$6.6m$50,000$1.1m
Shareholders' equity−$5.5m−$14.0m−$1.6m−$2.6m
Shares outstanding19m19m19m19m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021
Cash from operations−$4.2m−$1.9m−$881,736−$396,693
Capital spending−$4—−$4−$3
Free cash flow−$4.2m−$1.9m−$881,740−$396,696

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue—————$39,990$20,000—
Gross profit−$25,535−$31,980—−$18,308—$39,990$20,000—
Operating income−$14.1m−$7.6m−$13.7m−$7.3m−$5.7m−$37.6m−$2.1m−$2.2m
Net income−$14.2m−$8.8m−$15.5m−$8.6m−$5.7m−$38.0m−$2.3m−$2.2m
Diluted earnings per share-0.58-0.36-0.81-0.45-0.30-1.98-0.12-0.12
Cash from operations−$4.0m−$6.0m−$3.0m−$5.0m−$5.0m−$5.0m—−$3.0m
Total assets$5.2m$3.3m$2.8m$4.1m$3.0m$8.4m$3.4m$2.7m
Cash and short-term investments$2.0m$138,601$58,729$1.5m$125,039$5.4m$64,893$1.3m
Debt$73,669$72,348$6.0m$69,877$68,633—$24,722$244,368
Shareholders' equity−$18.5m−$13.2m−$17.5m−$11.8m−$11.8m−$9.6m−$5.5m−$5.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue26.0%——
Operating income174.8%——
Net income173.2%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin100.0%100.0%——

Valuation history

At each fiscal year end

FY2025
Price to earnings-2.6

Share price return

Finished calendar years

2025
Return-7%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.